Compare Align Technology, Inc. (ALGN) vs Veritone Inc (VERI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Veritone Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Veritone Inc trades at $1.17 (market cap $109.22M). The key difference: Align Technology, Inc. is far larger — about 117.7× Veritone Inc's market cap, and Align Technology, Inc. is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | VERI | |
|---|---|---|
Market Cap | $12.86B | $109.22M |
Sector | Health | Technology |
52-Week High | $207.19 | $8.39 |
52-Week Low | $124.88 | $1.18 |
Enterprise Value | $11.92B | $141.25M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Veritone (VERI) trades at $1.18, down 1.67% on the day, amid a bearish technical outlook and significant financial challenges. The company reported a net loss of $111.73 million in 2025, with negative profit margins and cash flow from operations. Recent news is dominated by multiple securities class action lawsuits alleging accounting irregularities, with a key deadline of July 20, 2026.
The outlook remains highly risky due to persistent losses, legal overhangs, and negative investor sentiment. While analyst consensus suggests substantial upside to a $5.25 price target, fundamental weaknesses and ongoing litigation present severe headwinds for shareholder value recovery in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
